{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T17:11:45Z","timestamp":1769879505092,"version":"3.49.0"},"reference-count":15,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Soc. Bras. Med. Trop."],"DOI":"10.1590\/0037-8682-0594-2019","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T06:24:17Z","timestamp":1592893457000},"source":"Crossref","is-referenced-by-count":4,"title":["Cost-utility analysis of interferon-free treatments for patients with early-stage genotype 1 hepatitis C virus in Brazil"],"prefix":"10.1590","volume":"53","author":[{"given":"Vinicius Lins","family":"Ferreira","sequence":"first","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leticia Paula","family":"Leonart","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Lucia Alves","family":"Pedroso","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7049-4363","authenticated-orcid":false,"given":"Roberto","family":"Pontarolo","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2020]]},"reference":[{"key":"ref1","series-title":"Hepatitis C - Key Facts","year":"2019"},{"key":"ref2","series-title":"Preven\u00e7\u00e3o e Controle das Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis, do HIV\/Aids e das Hepatites Virais. Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas para Hepatite C e Coinfec\u00e7\u00f5es","year":"2019"},{"key":"ref3","series-title":"Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection","year":"2014"},{"key":"ref4","series-title":"Diretrizes metodol\u00f3gicas : Diretriz de Avalia\u00e7\u00e3o Econ\u00f4mica","year":"2014","edition":"2\u00aa edi\u00e7\u00e3o"},{"key":"ref5","series-title":"Alguns dados sobre a situa\u00e7\u00e3o da Hepatite C no Brasil para ativistas de HIV\/AIDS","author":"Beloqui JA","year":"2017"},{"key":"ref6","series-title":"Guidelines for the Care and Treatment of Persons Diagnosed with Chronic Hepatitis C Virus Infection (Web Annex 3.1, Adult hepatitis C virus treatment systematic review)","year":"2018"},{"key":"ref7","series-title":"Produto Interno Bruto - PIB","year":"2019"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bjid.2018.04.003","article-title":"Effectiveness and tolerability of direct-acting antivirals for chronic hepatitis C patients in a Southern state of Brazil","volume":"22","author":"Ferreira VL","year":"2018","journal-title":"Braz J Infect Dis"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/jcpt.12426","article-title":"Safety of interferon-free therapies for chronic hepatitis C: a network meta-analysis","volume":"41","author":"Ferreira VL","year":"2016","journal-title":"J Clin Pharm Ther"},{"key":"ref10","article-title":"Baseline resistance associated substitutions in HCV genotype 1 infected cohort treated with Simeprevir, Daclatasvir and Sofosbuvir in Brazil","author":"Aguiar BF","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s12072-018-9873-y","article-title":"Glecaprevir\/pibrentasvir expands reach while reducing cost and duration of hepatitis C virus therapy","volume":"12","author":"Abutaleb A","year":"2018","journal-title":"Hepatol Int"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/j.jval.2018.04.572","article-title":"Cost\/Effectiveness Analysis of Direct-Acting Antivirals for Hepatitis C Virus in Treatment-Naive Genotype 1 without Cirrhosis Patients in Spanish Population","volume":"21","author":"Margusino-Frami\u00f1\u00e1n L","year":"2018","journal-title":"Value Health"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/j.jval.2018.04.573","article-title":"Cost-Effectiveness Analysis of Sofosbuvir\/Velpatasvir in Genotype 1 Hepatitis C Infected Patients in Mexico","volume":"21","author":"Azamar-Alonso A","year":"2018","journal-title":"Value Health"},{"key":"ref14","series-title":"Nota Informativa No 13\/2019-COVIG\/CGVP\/.DIAHV\/SVS\/MS","year":"2019"},{"key":"ref15","series-title":"Global Health Sector Strategies on Viral Hepatitis 2016-2021","year":"2016"}],"container-title":["Revista da Sociedade Brasileira de Medicina Tropical"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rsbmt\/v53\/1678-9849-rsbmt-53-e20190594.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T21:36:24Z","timestamp":1611437784000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0037-86822020000100651&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":15,"alternative-id":["S0037-86822020000100651"],"URL":"https:\/\/doi.org\/10.1590\/0037-8682-0594-2019","relation":{},"ISSN":["1678-9849","0037-8682"],"issn-type":[{"value":"1678-9849","type":"electronic"},{"value":"0037-8682","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"article-number":"e20190594"}}